Increase of the Cold Kits Manufacturing Facility

RPH Pharma, the cold kit industry,   will increase its plant in Porto Alegre, where it is located. 

Currently, serves about 90% of the Brazilian nuclear medicine market. From 2019, RPH Pharma will become the most modern Cold Kits plant in Latin American market.

The  enlargement  will enable the expansion of production capacity and a significant increase in the portfolio of products already offered by RPH Pharma, ensuring the sustainability of supplying Cold Kits to a market that is constantly growing.